CHESTERBROOK, Pa.--(BUSINESS WIRE)--Neuraptive Therapeutics, Inc., a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI), today announced ...
AUSTIN, Texas--(BUSINESS WIRE)--#AAOHNSF--Oticara, an emerging pharmaceutical company advancing physician-delivered treatments for chronic rhinosinusitis (CRS), today announced that new late-breaking ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...
A new study has revealed how NHS waiting lists are pushing patients into risky choices - with some delaying or even avoiding care altogether, despite potential cancer symptoms. The survey of 2,000 ...
Around 2.8 million people live with MS worldwide with an average prevalence of 36 per 100,000 people. In Europe the average prevalence is even higher (133 per 100,000), with 300 per 100,000 in Germany ...
Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. BOSTON & MELBOURNE, Australia--(BUSINESS WIRE)--Monash University, ...
A new industry and academic consortium has been formed to advance OpenFold3, the latest version of the open-source AI model for molecular structure prediction. The AI Structural Biology consortium ...
Redditch Medical, the UK company specialising in cleanroom contamination control solutions, has been acquired by German healthcare company Schülke & Mayr. The deal provides an exit for Traditum ...
PORTO, Portugal--(BUSINESS WIRE)--#bial--Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a significant milestone in its ongoing Phase 2 ...
Ideagen, a global leader in software for regulated and high-compliance industries, today announced the acquisition of SafetyStratus, a Texas-based provider of enterprise environmental, health and ...
Hosted by Biogen, the Colloquium brings together leading investigators and physicians with patients, partners and supporters to discuss progress in addressing nano-rare illnessesn-Lorem has ...
DUBLIN--(BUSINESS WIRE)--The "Positive Persuading and Influencing Skills for Pharma Professionals (Nov 10th - Nov 13th, 2025)" training has been added to ResearchAndMarkets.com's offering. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback